Welcome to our dedicated page for AMERICAN HEALTHCARE REIT news (Ticker: AHR), a resource for investors and traders seeking the latest updates and insights on AMERICAN HEALTHCARE REIT stock.
American Healthcare REIT reports developments for a healthcare-focused REIT that owns clinical healthcare real estate across integrated senior health campuses, outpatient medical properties, triple-net leased assets and senior housing operating properties. Company news commonly covers quarterly results, same-store NOI trends, occupancy and rate dynamics, guidance, distributions and portfolio activity, including non-core property sales and development or expansion projects.
Updates also address capital-market presentations, leadership continuity and the operating performance of senior housing platforms such as Trilogy Management Services and regional operating partners.
American Healthcare REIT (NYSE: AHR) priced an underwritten public offering of 13,250,000 common shares via forward sale agreements, with expected aggregate gross proceeds of approximately $712.2 million before expenses. Underwriters have a 30-day option to buy up to 1,987,500 additional shares. Forward purchasers are expected to borrow and sell the shares to underwriters, with physical settlement of the forward agreements expected within about 24 months. According to American Healthcare REIT, net proceeds upon settlement are expected to fund a pending senior housing portfolio acquisition, potential future investments and general corporate purposes.
American Healthcare REIT (NYSE: AHR) has launched an underwritten public offering of 13,250,000 common shares structured via forward sale agreements with Morgan Stanley, Citigroup and KeyBanc Capital Markets, which are also joint book-running managers. Underwriters have a 30-day option to purchase up to an additional 1,987,500 shares.
Forward purchasers (or affiliates) are expected to borrow and sell these shares to the underwriters, with the company intending to physically settle the forward sale agreements within about 24 months, issuing up to 15,237,500 shares in total if the option is fully exercised. The company will receive cash only upon settlement and plans to contribute net proceeds to its operating partnership for a pending senior housing portfolio acquisition, potential future investments and general corporate purposes.
American Healthcare REIT (NYSE: AHR) reported second quarter 2026 GAAP net income attributable to controlling interest of $30.6 million, or $0.16 per diluted share, and Normalized FFO of $0.54 per diluted share. Total portfolio Same-Store NOI grew 13.2% year-over-year, led by 20.5% growth in SHOP and 16.1% in ISHC.
The company completed approximately $126.9 million of SHOP acquisitions in the quarter and over $1.4 billion in new investments since the start of 2026, plus a further $1.0 billion of SHOP acquisitions and an $86.2 million loan with purchase options after quarter end. It raised equity via a May 2026 follow-on offering and ATM forward sales totaling more than $2.6 billion in gross proceeds issued or contracted, improving Net Debt-to-Annualized Adjusted EBITDA from 3.0x to 2.5x. Full-year 2026 NFFO per diluted share guidance increased to $2.15–$2.19 and total portfolio Same-Store NOI growth guidance to 11.0%–13.0%.
American Healthcare REIT (NYSE: AHR) announced a leadership transition effective immediately. Jeff Hanson, previously Interim CEO and longtime Chairman, has been appointed Chief Executive Officer. Gabe Willhite, currently Chief Operating Officer, has been elevated to President. Company co-founder Danny Prosky has retired from his President and CEO roles but remains on the Board and will continue as an advisor to management.
The Board also named independent director Scott Estes as Lead Independent Director. According to American Healthcare REIT, these moves are intended to support the company’s next phase of growth, platform scaling and corporate governance strength.
American Healthcare REIT (NYSE:AHR) will release its second quarter 2026 earnings on Thursday, August 6, 2026, after market close. A public conference call and simultaneous webcast will follow on Friday, August 7, 2026, at 10:00 a.m. PT / 1:00 p.m. ET.
Executives will review Q2 2026 results, discuss recent events, and host a Q&A session. Webcast and replay access will be available through the company’s investor relations website.
American Healthcare REIT (NYSE:AHR) declared a quarterly cash distribution of $0.25 per share for the quarter ending June 30, 2026.
The distribution is payable on or about July 17, 2026 to common stockholders of record at the close of business on June 30, 2026.
American Healthcare REIT (NYSE:AHR) will present at Nareit’s REITweek: 2026 Investor Conference on June 2, 2026, from 11:00 a.m. to 11:30 a.m. Eastern Time.
Senior leadership will deliver the presentation, which will be accessible via live webcast with a replay available for up to 60 days.
American Healthcare REIT (NYSE:AHR) priced an underwritten public offering of 14,000,000 common shares via a forward sale agreement with BofA Securities. Expected gross proceeds are about $705.6 million, before expenses, assuming full physical settlement.
The underwriter has a 30-day option for up to 2,100,000 additional shares, bringing the total to 16,100,000 shares. The offering is expected to close on May 22, 2026, with forward settlements targeted within about 24 months. Net proceeds are expected to fund general corporate purposes and potential future investments.
American Healthcare REIT (NYSE:AHR) commenced an underwritten public offering of 14,000,000 common shares via a forward sale agreement with BofA Securities, which may rise to 16,100,000 shares if the underwriter’s 30-day option is fully exercised.
The company expects to physically settle the forward agreements within about 24 months, then receive cash proceeds at the forward sale price. Net proceeds are expected to be used for general corporate purposes, including potential future investments.
American Healthcare REIT (NYSE: AHR) reported Q1 2026 results and raised full‑year guidance on May 7, 2026. Key metrics: GAAP net income $23.7M ($0.13/diluted), NFFO $0.50/diluted (+>30% YoY), Total Same‑Store NOI +12.1% and liquidity ~ $1.31B. The company closed ~$162.8M of SHOP investments and has unsettled ATM forward sales for ~10.5M shares (~$527.4M).
Guidance: NFFO $2.03–2.09 and Total SS NOI 9.0%–12.0% for FY2026; Net‑Debt/Adj. EBITDA improved to 3.0x.